Discoveries from AAO

Most patients in the IRIS Registry and Komodo Database who initiated brolucizumab previously used another form of anti-VEGF treatment, according to research presented at the virtual American Academy of Ophthalmology annual meeting.

Artificial intelligence-based telemedicine platform may allow for large-scale screening of patients with age-related macular degeneration while lowering the cost of care, according to a poster at AAO Annual Meeting.

Vision outcomes using a port delivery system proved equivalent to ranibizumab injections and showed a positive benefit profile, according to data presented at the virtual American Academy of Ophthalmology annual meeting.

Subretinal fluid volatility may play a key role in predicting visual acuity outcomes of neovascular age-related macular degeneration, according to research presented at the virtual American Academy of Ophthalmology annual meeting.

Diana Do, MD, professor of ophthalmology at Stanford University, discussed her presentation on the comparison of the efficacy of multiple anti-VEGF treatments in wet AMD at the virtual American Academy of Ophthalmology annual meeting.

An antibody biopolymer conjugate showed safety, efficacy and durability compared to aflibercept in various retinal conditions, according to research presented at the virtual American Academy of Ophthalmology annual meeting.

Public insurance, less education and health care access and resources contribute to risk of developing diabetic eye disease complications, according to results presented at the virtual American Academy of Ophthalmology annual meeting.

Long-term study results of glaucoma implant tube surgery presented at the virtual American Academy of Ophthalmology annual meeting showed posterior tubes were equally effective at lowering intraocular pressure as anterior counterparts and displayed a low rate of erosion.

The phase 1 study of GEM103 and geographic atrophy met all endpoints, according to research presented at the virtual American Academy of Ophthalmology annual meeting.

Angiogenesis required the coordinated function of regulatory and effector proteins, including the VEGF, TIE, angiopoietin and integrin families, Peter K. Kaiser, MD, of the Cole Eye Institute at Cleveland Clinic, said in a video interview.